{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:02:47Z","timestamp":1792105367198,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jgo.2023.101472","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T20:22:25Z","timestamp":1678911745000},"page":"101472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: A cross-sectional study"],"prefix":"10.1016","volume":"14","author":[{"given":"Sunghwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Hye","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2023.101472_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12875-020-01127-8","article-title":"Primary care service use by end-of-life cancer patients: a nationwide population-based cohort study in the United Kingdom","volume":"21","author":"Gao","year":"2020","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jgo.2023.101472_bb0010","first-page":"452","article-title":"Less is more: polypharmacy at the end of life","volume":"23","author":"Barak","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jgo.2023.101472_bb0015","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S1470-2045(15)00080-7","article-title":"Polypharmacy in patients with advanced cancer and the role of medication discontinuation","volume":"16","author":"LeBlanc","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2023.101472_bb0020","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1634\/theoncologist.2019-0085","article-title":"Polypharmacy, inappropriate medication use, and drug interactions in older Korean patients with cancer receiving first-line palliative chemotherapy","volume":"25","author":"Hong","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2023.101472_bb0025","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jpainsymman.2014.03.008","article-title":"Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients","volume":"48","author":"Kotlinska-Lemieszek","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jgo.2023.101472_bb0030","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.32044","article-title":"Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing?","volume":"125","author":"Morin","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2023.101472_bb0035","first-page":"1313","article-title":"Use of unnecessary medications by patients with advanced cancer: cross-sectional survey","volume":"19","author":"Fede","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2023.101472_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/11632610-000000000-00000","article-title":"Inappropriate prescribing: criteria, detection and prevention","volume":"29","author":"O\u2019Connor","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jgo.2023.101472_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jgo.2019.01.024","article-title":"Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer","volume":"10","author":"Karuturi","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101472_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjh.15027","article-title":"Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities","volume":"180","author":"Lin","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2023.101472_bb0055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s40520-018-0904-2","article-title":"Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment","volume":"30","author":"Choi","year":"2018","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jgo.2023.101472_bb0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00432-015-2108-x","article-title":"Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer","volume":"142","author":"Park","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101472_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12877-016-0311-5","article-title":"Association of pre-operative medication use with post-operative delirium in surgical oncology patients receiving comprehensive geriatric assessment","volume":"16","author":"Jeong","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jgo.2023.101472_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jgo.2015.04.003","article-title":"Geriatric assessment as predictors of hospital readmission in older adults with cancer","volume":"6","author":"Chiang","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101472_bb0075","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.leukres.2014.06.018","article-title":"The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML)","volume":"38","author":"Elliot","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.jgo.2023.101472_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jgo.2012.02.005","article-title":"Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with Cancer","volume":"3","author":"Prithviraj","year":"2012","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101472_bb0085","first-page":"1113","article-title":"Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches","volume":"22","author":"Lindsay","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2023.101472_bb0090","first-page":"600","article-title":"STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.jgo.2023.101472_bb0095","first-page":"71","article-title":"The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019","volume":"23","author":"Lindsay","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2023.101472_bb0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00228-019-02630-3","article-title":"STOPPFrail (screening tool of older Persons\u2019 prescriptions in frail adults with a limited life expectancy) criteria: application to a representative population awaiting long-term nursing care","volume":"75","author":"Lavan","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2023.101472_bb0105","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/jpm.2018.0559","article-title":"A study of medication use of cancer and non-cancer patients in home hospice care in Singapore: a retrospective study from 2011 to 2015","volume":"22","author":"Wenedy","year":"2019","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jgo.2023.101472_bb0110","first-page":"4107","article-title":"The impact of palliative care consults on deprescribing in palliative cancer patients","volume":"28","author":"Marin","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2023.101472_bb0115","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jgo.2023.101472_bb0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the SHELTER study","volume":"67","author":"Onder","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jgo.2023.101472_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s41999-018-0073-z","article-title":"Potentially inappropriate medication in palliative care patients according to STOPP-frail criteria","volume":"9","author":"Sevilla-S\u00e1nchez","year":"2018","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jgo.2023.101472_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/bmjspcare-2015-000941","article-title":"Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review","volume":"7","author":"Todd","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jgo.2023.101472_bb0135","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.21037\/apm-21-1788","article-title":"Potentially inappropriate medication discontinued or changed based on pharmacists\u2019 recommendations in older end-stage cancer patients receiving palliative care: a cross-sectional study","volume":"10","author":"Takahashi","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jgo.2023.101472_bb0140","article-title":"Therapeutic futility in terminal Cancer patients: a retrospective and observational study","volume":"13","author":"Gra\u00e7a","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jgo.2023.101472_bb0145","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/bcp.13874","article-title":"Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases","volume":"85","author":"Paque","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2023.101472_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/jpm.2020.0225","article-title":"Polypharmacy in palliative care: two Deprescribing tools compared with a clinical review journal of palliative medicine","volume":"24","author":"McNeill","year":"2021","journal-title":"J Palliat Med"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:57:15Z","timestamp":1761818235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406823000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1879406823000693"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101472","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101472"}}